This review aims to explore the effects of GLP-1R signaling on various immune cells and evaluate the therapeutic potential of GLP-1RAs in autoimmune and autoinflammatory diseases, including psoriasis, inflammatory bowel diseases, rheumatoid arthritis, asthma, multiple sclerosis, Sjgrens syndrome, and systemic lupus erythematosus
V.ChappleC.NovoselovS
This product is not a drug, supplement, therapy, or consumable product
Do not use these medicines together with other medicines that contain semaglutide, tirzepatide or any other GLP-1 or GLP-1/GIP receptor agonists, unless your doctor tells you to
While not considered dangerous to humans, bites can result in localized symptoms such as swelling or discomfort